EICHOR
● Completed
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
Condition: Severe Aortic Stenosis · Sponsor: Medtronic Cardiovascular
About this study
To evaluate the safety and efficacy of the Medtronic CoreValve® System for the treatment of symptomatic severe aortic stenosis in subjects with significant comorbidities in whom the risk of surgical aortic valve replacement has a predicted operative mortality or serious, irreversible morbidity risk of ≥50% at 30 days.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (43)
| Banner Good Samaritan | Phoenix, Arizona, United States | — |
| Kaiser Permanente - Los Angeles Medical Center | Los Angeles, California, United States | — |
| University of Southern California University Hospital | Los Angeles, California, United States | — |
| VA Palo Alto Health Care System | Palo Alto, California, United States | — |
| Hartford Hospital | Hartford, Connecticut, United States | — |
| Yale New Haven Hospital | New Haven, Connecticut, United States | — |
| Washington Hospital Center / Georgetown Hospital | Washington D.C., District of Columbia, United States | — |
| University of Miami Health System / Jackson Memorial Hospital | Miami, Florida, United States | — |
| Mount Sinai Medical Center | Miami Beach, Florida, United States | — |
| Piedmont Heart Institute | Atlanta, Georgia, United States | — |
| Saint Joseph's Hospital of Atlanta | Atlanta, Georgia, United States | — |
| Loyola University Medical Center | Maywood, Illinois, United States | — |
+ 31 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01675440